 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval/ R) u6 D3 X }0 K* z
I9 l8 @4 M3 I
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.! R; u* v) [+ r: e0 _
% x' R- a& m( y' Y- {BY THE EDMONTON JOURNAL FEBRUARY 16, 2007* Z6 {" o1 P# B8 Y, A5 p' X0 j
4 x b( r" L" q! l. ]: [* s : A$ R _, k9 x+ m) J, g
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
' ~6 P( u/ N2 F- n& I( K7 ^2 v
5 S% ?! I! ~" }# D- R) D- TThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
" E0 U; l5 k" X: m2 ^' Q3 z# Q. M4 f$ f
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
V. F! G, y. X3 w6 }% x. N
9 N7 O0 {& G+ F: pIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
- b& G2 O- r& j8 K7 T* R
$ y( ?- j& O( ^3 NIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.4 [) G/ W6 }! \6 U$ l9 ~, Y$ j$ i
, C. `& p- Y0 Y, U+ k2 @5 Z9 x
"As a scientist, it's one of the highlights of my CAREER," Shan said.
/ F7 U1 W$ f* w3 Y) n8 D+ k& ]* ^ h2 v }) F1 x
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
6 {# j: T, Z3 y2 i6 @* p5 Z" f
2 i+ x; F+ @. r( B1 P pIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
% J6 D4 W4 b4 T! K0 L" u
0 t+ z* r, G* Q# h e* |1 D! B! N* sGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
9 S7 Z0 v: [0 S+ _' V8 ]- `3 O8 d2 k! |
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
/ r9 F: [. |) P% M" S$ ]' n
% M: z. c' H/ f& s- V1 V
1 D6 t: I1 M8 m0 a* uhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|